The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis

Código QR

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis

Taro Kishi,* Shinji Matsunaga,* Nakao Iwata Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan *These authors contributed equally to this work Background: Memantine is effective in the treatment of behavioral disturbances in patients with Alzheimer&rs...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kishi T, Matsunaga S, Iwata N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	memantine Alzheimer’s disease behavioral disturbances meta-analysis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/3bdd7117fdeb4fec9dd35de13c7e46e9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi T, et al.
Publicado: (2018)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Stuart J Thomas, et al.
Publicado: (2009)

Memantine for the treatment of frontotemporal dementia: a meta-analysis
por: Kishi T, et al.
Publicado: (2015)

Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report
por: Duan JF, et al.
Publicado: (2018)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011)

Aberrant brain-stem morphometry associated with sleep disturbance in drug-naïve subjects with Alzheimer's disease
por: Lee JH, et al.
Publicado: (2016)

Update on the use of memantine in Alzheimer&rsquo;s disease
por: Robert J van Marum
Publicado: (2009)

Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
por: Zhong X, et al.
Publicado: (2017)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
por: Kano O, et al.
Publicado: (2013)

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Okuyama Y, et al.
Publicado: (2016)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
por: Kishi T, et al.
Publicado: (2017)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
por: Kishi T, et al.
Publicado: (2015)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
por: Umamon Puangthong, et al.
Publicado: (2009)

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study
por: Shiromaru-Sugimoto A, et al.
Publicado: (2018)

Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampus–prefrontal cortex dysconnectivity
por: Sampath D, et al.
Publicado: (2017)

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease
por: Giau VV, et al.
Publicado: (2018)

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
por: Zhou L, et al.
Publicado: (2016)

Alzheimer's disease and blood-based biomarkers – potential contexts of use
por: Zvěřová M
Publicado: (2018)

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study
por: Fujimoto H, et al.
Publicado: (2017)

Prediction of population with Alzheimer's disease in the European Union using a system dynamics model
por: Tomaskova H, et al.
Publicado: (2016)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

Sleep disturbances among patients with epilepsy
por: Staniszewska A, et al.
Publicado: (2017)

Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
por: Xin-Yu Yang, et al.
Publicado: (2021)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021)

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease
por: Zhong M, et al.
Publicado: (2021)

The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of <i>N</i>-Methyl-<span style="font-variant: small-caps">d</span>-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer’s Disease Application
por: Jung Sun Park, et al.
Publicado: (2021)

Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
por: Haiyan Liu, et al.
Publicado: (2021)

Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives
por: Karthik S, et al.
Publicado: (2020)

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Hannah Walgrave, et al.
Publicado: (2021)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Oya K, et al.
Publicado: (2015)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

Alzheimer's disease and its treatment costs: case study in the Czech Republic
por: Mohelska H, et al.
Publicado: (2015)

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
por: Chow TW, et al.
Publicado: (2011)

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi T, et al.
Publicado: (2019)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan
por: Li DJ, et al.
Publicado: (2018)

A SENSITIVE SEQUENTIAL INJECTION ANALYSIS (SIA) DETERMINATION OF MEMANTINE HYDROCHLORIDE USING LUMINOL-HYDROGEN PEROXIDE INDUCED CHEMILUMINESCENCE DETECTION
por: ALARFAJ,NAWAL A, et al.
Publicado: (2014)